SFS
NVCR icon

Sowell Financial Services’s NovoCure NVCR Stock Holding History

Sowell Financial Services’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-329
Closed -$64K – 1994
2021
Q1 		$64K Sell
329
-142
-30% -$22.5K ﹤0.01% 1548
2020
Q4 		$82K Sell
471
-1,045
-69% -$143K ﹤0.01% 1224
2020
Q3 		$169K Sell
1,516
-365
-19% -$29.2K 0.01% 789
2020
Q2 		$112K Buy
1,881
+1,129
+150% +$74.3K 0.01% 929
2020
Q1 		$51K Sell
752
-96
-11% -$7.59K ﹤0.01% 1055
2019
Q4 		$71K Buy
848
+726
+595% +$58.6K 0.01% 1016
2019
Q3 		$9K Buy
+122
New +$9.76K ﹤0.01% 1570
2017
Q1 		– Sell
-100
Closed -$1K – 476
2016
Q4 		$1K Buy
+100
New +$804 ﹤0.01% 623

Other funds holding NVCR

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sowell Financial Services's NVCR Position: Q2 2021 in Review

Sowell Financial Services sold out of NovoCure (NVCR) in Q2 2021, closing a stake of 329 shares — an estimated $64K sold.

Sowell Financial Services first reported a position in NVCR in Q4 2016 and held it in 8 quarters. The position peaked at $169K in Q3 2020. 362 funds tracked by Wall St. Rank hold NVCR as of Q2 2021.

  • Sowell Financial Services reported no remaining NovoCure position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 329 NovoCure shares in Q2 2021, an estimated $64K.
  • Sowell Financial Services first reported a position in NovoCure in Q4 2016 and held it in 8 quarters.
  • Sowell Financial Services's NovoCure position peaked at $169K in Q3 2020.
  • 362 funds tracked by Wall St. Rank held NovoCure as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.